MedImmune, the global biologics research and development arm of AstraZeneca, today announced that it has entered into a new five year Scientific and Technological Cooperation Agreement with the São Paulo Research Foundation (FAPESP), an independent public foundation with the mission to foster research and the scientific and technological development of the State of São Paulo in Brazil. This collaboration, which is the result of a cross-functional effort among MedImmune, AstraZeneca Brazil, and the State of São Paulo, will focus on identifying and accessing the best science and scientists in the cardiovascular and metabolic disease areas at São Paulo’s public and private research institutions.
{iframe}https://www.medimmune.com/media/press-releases/2015/03/19/medimmune-establishes-collaboration-with-são-paulo-research-foundation-to-identify-new-early-research-projects-in-brazil{/iframe}